Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
Home
ETF
IMNN
IMNN
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
IMNN News
Imunon Reports Improved Survival Rates and Extended Operating Runway
Mar 31 2026
Yahoo Finance
Imunon Q4 2025 Earnings Call Highlights
Mar 31 2026
seekingalpha
Imunon Reports FY Losses, EPS at -$6.83
Mar 31 2026
seekingalpha
Imunon Scheduled to Announce Q4 Earnings on March 30
Mar 30 2026
seekingalpha
Biotech Landscape Update: Regulatory Approvals and Mergers
Mar 27 2026
NASDAQ.COM
IMUNON Secures $7 Million from Institutional Investor in Direct Stock Offering
Dec 30 2025
Newsfilter
IMUNON Advances OVATION3 Study, Aiming for Breakthrough Therapy
Dec 29 2025
Globenewswire
IMUNON Advances OVATION3 Study, Aiming for Breakthrough Therapy
Dec 29 2025
Newsfilter
Imunon (IMNN) Q3 2025 Earnings Conference Call Transcript
Nov 13 2025
NASDAQ.COM
IMUNON Releases Financial Results for Q3 2025 and Offers Business Update
Nov 13 2025
Newsfilter
IMUNON's Public Webcast Showcases Resilience and Innovation in the Quest for the First Approved Ovarian Cancer Immunotherapy
Nov 10 2025
Newsfilter
IMUNON R&D Day: Chance to Listen to Clinical Trial Researchers Discuss the Promising Impact of IMNN-001 on Ovarian Cancer Therapy
Nov 07 2025
Newsfilter
VTYX, MEDP, INBX Surge in After-Hours Trading Following Important Announcements
Oct 23 2025
NASDAQ.COM
IMUNON Holds R&D Day Showcasing Advances in OVATION 3 Study Aiming for First-Line Immunotherapy for Advanced Ovarian Cancer
Oct 20 2025
Newsfilter
IMUNON to Showcase New Translational Data for IMNN-001 in Support of Phase 3 Ovarian Cancer Immunotherapy Trial at AACR Special Conference on Cancer Research
Sep 19 2025
Newsfilter
IMUNON Achieves Compliance with Nasdaq's Minimum Bid Price Requirement
Aug 28 2025
Newsfilter
Show More News
